The FDA typically has very strict guidelines for pharmaceutical manufacturers to follow before their products can be sold on the market. However during times of global crisis, that may not always be the case.
Microplastics, or very small solid particles composed of mixtures of polymers and functional additives, have some strict guidelines in the EU. Read on to find out more.
On January 31st, the UK left the EU - but did they really leave it? Let's find out how Brexit may change the regulatory landscape and the impact it could have on the medical industry at large.